Daan Hellingman
Papers
2
Total Citations
10
H-Index
2
About
Daan Hellingman is a biomedical engineer and researcher whose work sits at the intersection of nuclear medicine, surgical robotics, and breast cancer diagnostics. His primary research focus is the development of high-precision, minimally invasive biopsy techniques guided by molecular imaging. Hellingman’s most notable contribution is the design and validation of a novel semi-robotized device for 18F-FDG-guided breast cancer biopsy, a technology that enables surgeons to target metabolically active lesions with exceptional accuracy. This work, published in 2016 and 2017, has garnered attention for its potential to reduce false negatives and improve early detection. While his citation count is modest, the clinical relevance of his device is significant, representing a step toward integrating robotics with PET-guided procedures. Hellingman’s research bridges engineering and oncology, offering a tangible solution to the challenge of sampling small or non-palpable tumors. His work continues to influence the design of image-guided intervention systems, making him a promising figure in the field of precision cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2